Literature DB >> 11730268

Risk factors for hospitalizations resulting from pulmonary embolism after renal transplantation in the United States.

D P Tveit1, I Hypolite, J Bucci, P Hshieh, D Cruess, L Y Agodoa, P G Welch, K C Abbott.   

Abstract

BACKGROUND: Risk factors for pulmonary embolism (PE) have been identified in the general population but have not been studied in a national population of renal transplant recipients.
METHODS: Therefore, 33,479 renal transplant recipients in the United States Renal Data System from 1 July 1994-30 June 1997 were analyzed in a historical cohort study of hospitalized PE (ICD9 Code 415.1x). HCFA form 2728 was used for comorbidities.
RESULTS: Renal transplant recipients had an incidence of PE of 2.26 hospitalizations per 1000 patient years at risk. In multivariate analysis, polycystic kidney disease (adjusted odds ratio, 4.44, 95% confidence interval, 2.31-8.53), older recipient age, higher recipient weight, cadaveric donation, history of ischemic heart disease, and decreased serum albumin were associated with increased risk of PE. Body mass index and hemoglobin were not significant. Kidney-pancreas transplantation was also not significant. In Cox Regression analysis PE was associated with increased mortality (hazard ratio 2.06, 95% CI 1.34-3.18).
CONCLUSIONS: The most important risk factors for PE in this population were polycystic kidney disease, advanced age and increased weight. The reasons for the increased risk of polycystic kidney disease remain to be determined but were independent of hematocrit level at initiation of end stage renal disease, and may result from venous compression. Prospective studies of anatomical and hemostatic changes after renal transplantation in recipients with polycystic kidney disease are warranted.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11730268

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  5 in total

1.  Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials.

Authors:  Jean-Louis Vincent; Marc-Jacques Dubois; Roberta J Navickis; Mahlon M Wilkes
Journal:  Ann Surg       Date:  2003-03       Impact factor: 12.969

2.  Low-dose rapamycin (sirolimus) effects in autosomal dominant polycystic kidney disease: an open-label randomized controlled pilot study.

Authors:  William E Braun; Jesse D Schold; Brian R Stephany; Rita A Spirko; Brian R Herts
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237

Review 3.  Prophylaxis of Pulmonary Embolism in Kidney Transplant Recipients.

Authors:  Federico Cicora; Jorgelina Petroni; Javier Roberti
Journal:  Curr Urol Rep       Date:  2018-02-23       Impact factor: 3.092

4.  Hospitalized poisonings after renal transplantation in the United States.

Authors:  Kevin C Abbott; Rebecca A Viola; Lawrence Y Agodoa
Journal:  BMC Nephrol       Date:  2002-11-26       Impact factor: 2.388

5.  Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome after renal transplantation in the United States.

Authors:  Kevin C Abbott; Victor J Bernet; Lawrence Y Agodoa; Christina M Yuan
Journal:  BMC Endocr Disord       Date:  2003-03-24       Impact factor: 2.763

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.